KMT2A and leukemia: Moreover, while MLL1-ENL without MBM (Menin-binding motif 1–40) cannot cause leukemic transformation, replacement of MBM with LEDGF PWWP (1–93) enabled the engineered MLL-ENL to cause leukemia [114].